The Silicon Valley start-ups that often grab headlines are typically in the Internet and consumer technology world. But there’s another part of start-up land that is also highly active: health-related technology, which includes biotech, health care services and medical devices.
Venture capitalists have been pouring money into health-related start-ups, with funding jumping 34 percent to $9.4 billion in 2014 from a year earlier, according to the National Venture Capital Association. What’s often left unsaid about these companies is that they behave very differently from the typical consumer start-up or business software company.
The health-related start-up sector has produced fewer unicorns, which are the private companies with $1 billion-plus valuations, largely because it takes a long time to develop new medical tests, drugs or insurance systems. Regulators often weigh in. Even if an idea behind a start-up is truly great, it’s bound to fail if the science doesn’t work out, if the regulators don’t like what they see, or if insurers and the government won’t pay for the product. For the full article click here
from health IT caucus http://ift.tt/20zE3Hh
via IFTTT
No comments:
Post a Comment